Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030587046> ?p ?o ?g. }
- W2030587046 endingPage "559" @default.
- W2030587046 startingPage "559" @default.
- W2030587046 abstract "<h3>Objective</h3> To determine whether warfarin-treated patients with an international normalized ratio less than 1.7 who receive intravenous tissue plasminogen activator for acute ischemic stroke are at increased risk for symptomatic intracerebral hemorrhage. <h3>Design</h3> Retrospective study. <h3>Setting</h3> Academic hospital. <h3>Patients</h3> Consecutive patients with acute ischemic stroke who are treated with intravenous tissue plasminogen activator. <h3>Main Outcome Measure</h3> Symptomatic intracerebral hemorrhage. <h3>Results</h3> One hundred seven patients were included (mean age, 69.2 years; 43.9% men; median National Institutes of Health Stroke Scale score, 14; median onset-to-treatment time, 140 minutes; baseline warfarin use, 12.1%). The median international normalized ratio was 1.04 (range, 0.82-1.61). The overall rate of symptomatic intracerebral hemorrhage was 6.5%, but it was nearly 10-fold higher among patients taking warfarin compared with those not taking warfarin at baseline (30.8% vs 3.2%, respectively;<i>P</i> = .004). Baseline warfarin use remained strongly associated with symptomatic intracerebral hemorrhage (<i>P</i> = .004) after adjusting for relevant covariates, including age, atrial fibrillation, National Institutes of Health Stroke Scale score, and international normalized ratio. <h3>Conclusions</h3> Despite an international normalized ratio less than 1.7, warfarin-treated patients are more likely than those not taking warfarin to experience symptomatic intracerebral hemorrhage following treatment with intravenous tissue plasminogen activator. Larger studies in this subgroup are warranted." @default.
- W2030587046 created "2016-06-24" @default.
- W2030587046 creator A5006104235 @default.
- W2030587046 creator A5022583053 @default.
- W2030587046 creator A5025187633 @default.
- W2030587046 creator A5039626665 @default.
- W2030587046 creator A5054364671 @default.
- W2030587046 creator A5058647871 @default.
- W2030587046 creator A5088034421 @default.
- W2030587046 date "2010-05-01" @default.
- W2030587046 modified "2023-09-23" @default.
- W2030587046 title "Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke" @default.
- W2030587046 cites W1980957569 @default.
- W2030587046 cites W1992181484 @default.
- W2030587046 cites W1994711619 @default.
- W2030587046 cites W2047788619 @default.
- W2030587046 cites W2061599477 @default.
- W2030587046 cites W2065063783 @default.
- W2030587046 cites W2065175417 @default.
- W2030587046 cites W2069334904 @default.
- W2030587046 cites W2071984852 @default.
- W2030587046 cites W2084350674 @default.
- W2030587046 cites W2098032054 @default.
- W2030587046 cites W2122794709 @default.
- W2030587046 cites W2132357532 @default.
- W2030587046 cites W2132505348 @default.
- W2030587046 cites W2137712463 @default.
- W2030587046 cites W2138595885 @default.
- W2030587046 cites W2139767844 @default.
- W2030587046 cites W2159233098 @default.
- W2030587046 cites W2292308933 @default.
- W2030587046 cites W2594075545 @default.
- W2030587046 cites W3208775091 @default.
- W2030587046 cites W2133310936 @default.
- W2030587046 doi "https://doi.org/10.1001/archneurol.2010.25" @default.
- W2030587046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20212195" @default.
- W2030587046 hasPublicationYear "2010" @default.
- W2030587046 type Work @default.
- W2030587046 sameAs 2030587046 @default.
- W2030587046 citedByCount "72" @default.
- W2030587046 countsByYear W20305870462012 @default.
- W2030587046 countsByYear W20305870462013 @default.
- W2030587046 countsByYear W20305870462014 @default.
- W2030587046 countsByYear W20305870462015 @default.
- W2030587046 countsByYear W20305870462016 @default.
- W2030587046 countsByYear W20305870462017 @default.
- W2030587046 countsByYear W20305870462018 @default.
- W2030587046 countsByYear W20305870462019 @default.
- W2030587046 countsByYear W20305870462020 @default.
- W2030587046 countsByYear W20305870462021 @default.
- W2030587046 crossrefType "journal-article" @default.
- W2030587046 hasAuthorship W2030587046A5006104235 @default.
- W2030587046 hasAuthorship W2030587046A5022583053 @default.
- W2030587046 hasAuthorship W2030587046A5025187633 @default.
- W2030587046 hasAuthorship W2030587046A5039626665 @default.
- W2030587046 hasAuthorship W2030587046A5054364671 @default.
- W2030587046 hasAuthorship W2030587046A5058647871 @default.
- W2030587046 hasAuthorship W2030587046A5088034421 @default.
- W2030587046 hasBestOaLocation W20305870461 @default.
- W2030587046 hasConcept C126322002 @default.
- W2030587046 hasConcept C127413603 @default.
- W2030587046 hasConcept C141071460 @default.
- W2030587046 hasConcept C164705383 @default.
- W2030587046 hasConcept C17624336 @default.
- W2030587046 hasConcept C2776301958 @default.
- W2030587046 hasConcept C2776572282 @default.
- W2030587046 hasConcept C2777094939 @default.
- W2030587046 hasConcept C2779161974 @default.
- W2030587046 hasConcept C2780645631 @default.
- W2030587046 hasConcept C42219234 @default.
- W2030587046 hasConcept C71924100 @default.
- W2030587046 hasConcept C78519656 @default.
- W2030587046 hasConceptScore W2030587046C126322002 @default.
- W2030587046 hasConceptScore W2030587046C127413603 @default.
- W2030587046 hasConceptScore W2030587046C141071460 @default.
- W2030587046 hasConceptScore W2030587046C164705383 @default.
- W2030587046 hasConceptScore W2030587046C17624336 @default.
- W2030587046 hasConceptScore W2030587046C2776301958 @default.
- W2030587046 hasConceptScore W2030587046C2776572282 @default.
- W2030587046 hasConceptScore W2030587046C2777094939 @default.
- W2030587046 hasConceptScore W2030587046C2779161974 @default.
- W2030587046 hasConceptScore W2030587046C2780645631 @default.
- W2030587046 hasConceptScore W2030587046C42219234 @default.
- W2030587046 hasConceptScore W2030587046C71924100 @default.
- W2030587046 hasConceptScore W2030587046C78519656 @default.
- W2030587046 hasIssue "5" @default.
- W2030587046 hasLocation W20305870461 @default.
- W2030587046 hasLocation W20305870462 @default.
- W2030587046 hasLocation W20305870463 @default.
- W2030587046 hasOpenAccess W2030587046 @default.
- W2030587046 hasPrimaryLocation W20305870461 @default.
- W2030587046 hasRelatedWork W1983415041 @default.
- W2030587046 hasRelatedWork W2003235938 @default.
- W2030587046 hasRelatedWork W2081145557 @default.
- W2030587046 hasRelatedWork W2114223015 @default.
- W2030587046 hasRelatedWork W2157689025 @default.
- W2030587046 hasRelatedWork W2274835053 @default.
- W2030587046 hasRelatedWork W2415605004 @default.